ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

292
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
14 Nov 2018 17:09

Samsung Biologics: A Temporary Suspension of Shares Trading

The Korean financial regulators announced a temporary suspension of shares trading for Samsung Biologics Co., (207940 KS) as of today, mainly due...

Logo
476 Views
Share
bullishSamsung C&T
13 Nov 2018 07:59

Samsung C&T Stub Trade: Holdco Discount Still at a Historic Low Despite BioLogics Misfortune

Samsung C&T (028260 KS) holdco discount is still at a historic low despite Samsung Biologics Co., (207940 KS)' recent misfortune....

Logo
380 Views
Share
12 Nov 2018 12:19

The Odd Timing of the Final Rule on Samsung Biologics and Firing of Kim Dong-Yeon & Jang Ha-Sung

It was reported in numerous local Korean media today that the final decision by the regulators on the fate of Samsung Biologics Co., (207940...

Logo
347 Views
Share
22 Oct 2018 22:52

Samsung BioLogics Update

Recent developments in Samsung Biologics Co., (207940 KS)'s business have been mixed with a negative skew. First, partner Merck & Co Inc (MRK...

Share
bearishCelltrion Inc
22 Oct 2018 19:04

Celltrion Inc Placement - Shorter Lockup Period Will Be an Overhang for Share Price

Ion Investment (Temasek) is looking to sell about 3.4m shares in Celltrion Inc (068270 KS) in an accelerated bookbuild worth approximately US$740m....

Share
x